>
Switch to:

Calliditas Therapeutics AB Cash-to-Debt

: No Debt (As of Dec. 2020)
View and export this data going back to 2020. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Calliditas Therapeutics AB's cash to debt ratio for the quarter that ended in Dec. 2020 was No Debt.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Calliditas Therapeutics AB could pay off its debt using the cash in hand for the quarter that ended in Dec. 2020.

NAS:CALT' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.81   Med: 5062.07   Max: No Debt
Current: No Debt

0.81
No Debt

During the past 6 years, Calliditas Therapeutics AB's highest Cash to Debt Ratio was No Debt. The lowest was 0.81. And the median was 5062.07.

NAS:CALT's Cash-to-Debt is ranked higher than
100% of the 1054 Companies
in the Drug Manufacturers industry.

( Industry Median: 1.02 vs. NAS:CALT: No Debt )

Calliditas Therapeutics AB Cash-to-Debt Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Cash-to-Debt Premium Member Only 0.81 122.03 No Debt 124.14 No Debt

Calliditas Therapeutics AB Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Cash-to-Debt Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.14 No Debt No Debt No Debt No Debt

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Calliditas Therapeutics AB Cash-to-Debt Distribution

* The bar in red indicates where Calliditas Therapeutics AB's Cash-to-Debt falls into.



Calliditas Therapeutics AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Calliditas Therapeutics AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2020 is calculated as:

Calliditas Therapeutics AB had no debt.

Calliditas Therapeutics AB's Cash to Debt Ratio for the quarter that ended in Dec. 2020 is calculated as:

Calliditas Therapeutics AB had no debt.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Calliditas Therapeutics AB  (NAS:CALT) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Calliditas Therapeutics AB Cash-to-Debt Related Terms


Calliditas Therapeutics AB Cash-to-Debt Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)